-
Why Tilray's Stock Is Trading Higher Today
Thursday, March 26, 2020 - 3:00pm | 280Read More...Tilray Inc (NASDAQ: TLRY) shares are trading sharply higher potentially on a rebound following weakness in the sector. A DataTrek report suggested the negative impact from the coronavirus could accelerate legalization as states look for ways to recoup losses. The Canadian cannabis cultivator’...
-
More Consolidation In The Brokerage Space: PreMarket Prep Recap For Feb. 20, 2020
Thursday, February 20, 2020 - 1:01pm | 1499Read More...The big news on Thursday is Morgan Stanley’s (NYSE: MS) deal to acquire E*Trade Financial Corp (NASDAQ: ETFC) for $13 billion, or $58.74 per share. This marks the second major acquisition on the retail brokerage industry in the last four months, to go along with Charles Schwab’s (NYSE:...
-
PreMarket Prep Recap: Market-Moving News On Columbus Day
Monday, October 14, 2019 - 4:06pm | 932Read More...Despite the Columbus Day banking holiday, there was still a lot of news to cover on Monday's PreMarket Prep show. After the furious rally Friday, when a deal with China looked imminent, the market took the news that China wanted "more talks" in stride. At the start of the show, the S...
-
'420 Investor' Brochstein To CannTrust CEO: Apologize And Resign
Monday, July 8, 2019 - 10:58am | 596Read More..."420 Investor" Alan Brochstein has a simple message to CannTrust Holdings Inc (NYSE: CTC) CEO Peter Aceto: apologize for violating Health Canada rules and resign. What Happened CannTrust said in a press release Monday that it "accepted" a Health Canada finding that some of its...
-
Canopy Growth's Bruce Linton Out As Co-CEO: 'My Turn Is Over'
Wednesday, July 3, 2019 - 8:22am | 567Read More...Bruce Linton founded Canopy Growth Corp (NYSE: CGC) in 2013 and was the public face of the Canadian cannabis company until his resignation Wednesday. What Happened Canopy Growth announced Linton will step down as co-CEO and board member, effective immediately. The company's other co-CEO, Mark...
-
Canopy Growth's Bruce Linton 'Is Always One Step Ahead,' Says Harvest Health CEO
Thursday, April 18, 2019 - 2:11pm | 549Read More...On Thursday at Benzinga's Cannabis Capital Conference in Toronto, the room buzzed over Canopy Growth Corp (NYSE: CGC) and its acquisition of Acreage Holdings Inc (OTC: ACRGF). During the morning’s keynote, Harvest Health and Recreation (OTC: HRVSF) CEO Steve White said, "Bruce [...
-
Why The 420 Investor Likes Alcanna Going Forward
Friday, April 5, 2019 - 2:55pm | 519Read More...Alan Brochstein, author of "420 Investor" and founding partner of New Cannabis Ventures, appeared on Benzinga's PreMarket Prep show Friday morning and explained why he likes Alcanna Inc (OTC: LQSIF). What Happened Brochstein discussed why Alcanna, a Western Canada-based retailer of...
-
420 Investor: GW Pharma Investors May Have To Wait Out Short-Term Volatility
Monday, February 4, 2019 - 4:26pm | 703Read More...Investors in GW Pharmaceuticals PLC (NASDAQ: GWPH) may need to sit through some short-term volatility as sales of the company's newly approved drug ramp up slowly because of insurance coverage issues, says the author of The 420 Investor. Alan Brochstein, who is a founding partner of New...
-
Northland Downgrades Tilray After Huge Run
Thursday, September 6, 2018 - 10:13am | 423Read More...On Thursday, yet another analyst joined the growing chorus saying marijuana stock valuations are getting overheated. The Analyst Northland Capital Markets analyst Mike Grondahl downgraded Tilray Inc (NASDAQ: TLRY) from Outperform to Market Perform and removed its $60 price target. The Thesis...
-
Even Marijuana Bulls Are Becoming Skeptical Of US-Listed Cannabis Stock Prices
Wednesday, September 5, 2018 - 3:01pm | 959Read More...Cannabis stocks were again smoking Wednesday after Cronos Group Inc (NASDAQ: CRON) announced a partnership with Ginkgo Bioworks before to produce cannabinoids at scale. Analysts are optimistic about the future for the marijuana industry, but even cannabis bulls are increasingly skeptical of market...
-
What's The Difference Between Zynerba and GW Pharma's Epilepsy Drugs?
Friday, August 18, 2017 - 9:18am | 621Read More...The month of August has been hard one for cannabis drug stocks. After Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) reported a pair of disappointing trial results in its Phase 2 STAR 1 and STOP trials, respectively, the company’s market cap went up in smoke to the tune of a more than 50 percent...
-
GW Pharma Takes A Step Toward Diversifying
Tuesday, February 7, 2017 - 10:28am | 568Read More...Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Risk Mitigation Through Diversification The company announced Tuesday positive top...
-
GW Pharma Ending The Year On A High Note
Monday, December 5, 2016 - 12:48pm | 306Read More...Cannabinoid drug developer GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) is ending an eventful 2016 on a high note. Shares were surging higher by 6.6 percent on Monday following new drug data out over the weekend and a strong fiscal Q4 earnings report out Monday. Over the weekend, the company reported...
-
5 Of The Worst Marijuana Stocks Of 2016
Thursday, November 17, 2016 - 1:44pm | 519Read More...Marijuana gained some major momentum on Election Day, scoring ballot victories in California, Nevada, Massachusetts, Maine, Florida, North Dakota, Arkansas and Montana. Unfortunately, a federal ban on marijuana means that investing in marijuana stocks can be risky business. 5 Of The...
-
2 Big Medical Marijuana Stocks Riding High Post-Election
Thursday, November 10, 2016 - 11:45am | 455Read More...The surprise election of Donald Trump has gotten most of the election-related headlines following Tuesday’s vote. However, Tuesday was also a landmark day for the marijuana legalization movement. Marijuana scored medical and/or recreational victories in eight of the nine states that voted on...
















